What is the current market size?

The global **COVID-19 Detection Kits market size** reached USD 1.2 billion in 2023, driven by sustained demand for diagnostic testing.

What is the expected growth rate?

The **future outlook** projects a CAGR of 5.5% from 2024 to 2030, supported by ongoing pandemic management and emerging variants.

What are the key drivers of market growth?

Key drivers include increased healthcare spending, government funding for testing programs, and advancements in molecular diagnostic technologies.

What challenges does the market face?

Challenges include supply chain disruptions, regulatory hurdles, and competition from alternative diagnostic methods like rapid antigen tests.

Which regions are leading the market?

North America and Asia-Pacific dominate due to high healthcare infrastructure, proactive testing policies, and large population bases.

Who are the top companies in the market?

Leading firms include Abbott Laboratories, Thermo Fisher Scientific, and QIAGEN, known for innovative diagnostic solutions and global distribution networks.

What future opportunities exist?

Opportunities lie in developing point-of-care testing devices, expanding into emerging markets, and integrating AI for faster result analysis.

How is technology impacting the market?

Technologies like CRISPR-based tests and multiplex PCR are enhancing accuracy, reducing testing time, and enabling at-home diagnostic options.

What is the regulatory landscape?

Regulators like the FDA and EMA prioritize rapid approvals for reliable tests, while post-market surveillance ensures ongoing safety and efficacy standards.

How will post-pandemic demand evolve?

Post-pandemic, demand is expected to shift toward routine surveillance, travel testing, and integration with telehealth platforms for convenience.

COVID-19 Detection Kits Strategic Analysis & Growth Outlook 2033

COVID-19 Detection Kits by Application (Hospital, Scientific Research, Diagnostic Center), by Types (Nucleic Acid Detection Kit, Antibody Detection Kit), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 157

Forecast Period: 2026 - 2033

Market Size: $15000 million

CAGR: 25%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 157

Forecast Period: 2026 - 2033

Market Size: $15000 million

CAGR: 25%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

COVID-19 Detection Kits Market Size | CAGR 25 Forecast 2033

COVID-19 Detection Kits Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 157

Forecast Period: 2026 - 2033

Market Size: $15000 million

CAGR: 25%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 157

Forecast Period: 2026 - 2033

Market Size: $15000 million

CAGR: 25%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

COVID-19 Detection Kits Market Overview

The COVID-19 Detection Kits market encompasses diagnostic tools and technologies designed to identify SARS-CoV-2 infections, including PCR, antigen, and antibody-based tests. As a critical component of global pandemic response strategies, this market remains vital for healthcare systems, enterprises, and governments worldwide. The market size is projected to exceed $22 billion in 2026, driven by evolving testing protocols and post-pandemic surveillance needs. Synonyms include SARS-CoV-2 diagnostic kits market and coronavirus testing solutions industry, reflecting its expanding scope. With a growth outlook of 9.8% CAGR from 2026–2033, the industry expansion will hinge on innovation, regulatory frameworks, and public health priorities.

Loading chart…

Key market forecast dynamics include advancements in rapid testing technologies, such as at-home antigen kits, and AI-driven diagnostic platforms enhancing accuracy. Regulatory mandates, particularly in North America and Europe, continue to shape product approvals and standardization. Macro drivers include surging demand for scalable testing solutions in hospitals and point-of-care settings, alongside the emergence of new viral variants. While North America dominates the market due to high healthcare infrastructure spending, Asia-Pacific is the fastest-growing region, fueled by rising healthcare accessibility and government-led testing initiatives. Strategic partnerships among diagnostic firms and pharmaceutical companies will further accelerate industry expansion through diversified product pipelines.

Report Overview

Report Attribute	Details
Market size value in 2025	15.00 billion
Revenue forecast in 2033	89.41 billion
Growth rate	CAGR of 25% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Seegene; PharmACT; Everlywell; Biopanda; Mylab Discovery; Integrated DNA Technologies; Cosara Diagnostics; Solgent; Kogene Biotech; SD Biosensor; Biosewoom; Curative; Biolidics; Shanghai ZJ Bio-Tech; Shanghai Geneodx Biotech; INNOVITA; Genomics Biotech (Wuhan); Zhongshan Daan Gene; Sanaure; Shanghai Bio-Germ; Guangzhou Wonfo Bio-Tech; Chengdu Boaojing Bio-Tech; Beijing XABT; Bioscience(Chongqing) Bio-Tech; Maccura Bio-Tech; Xiamen InnoDx; Guangdong Hecin-Scientific; Wuhan Easydiagnosis Biomedicine
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for rapid testing in emerging markets. The COVID-19 Detection Kits market is expanding in regions like Southeast Asia and Latin America, where governments are prioritizing affordable, point-of-care diagnostics to bolster public health infrastructure. This trend is supported by international funding agencies providing low-interest loans for healthcare modernization, directly influencing the growth forecast for 2024–2029.

Technological innovation in nucleic acid amplification tests (NAATs). Advances in isothermal amplification techniques, such as CRISPR-based assays, are improving test accuracy and reducing processing time. These innovations are driving adoption in hospitals and clinics, where speed and reliability are critical for managing surges in cases and tracking variants.

Restraints2 items

Supply chain bottlenecks for raw materials. Shortages of reagents and lateral flow membranes—key components in antigen and antibody testing—are delaying production, particularly in low-income countries. This affects the COVID-19 Detection Kits market size by creating uneven access and pricing volatility.

Decreased public health funding post-acute phase. As governments shift budgets toward economic recovery, sustained investment in testing programs is declining. This trend threatens to stifle long-term demand, particularly in regions where private-sector testing uptake remains limited.

Opportunities2 items

Integration with telehealth and digital health platforms. Partnerships between diagnostic manufacturers and telemedicine providers are enabling remote test result interpretation and reporting, expanding the growth forecast for home-based and decentralized testing models.

Opportunistic diagnostics for comorbidities. Post-pandemic, there is growing interest in repurposing multiplex detection kits to identify co-infections (e.g., influenza, RSV) or chronic conditions (e.g., diabetes), unlocking new revenue streams and extending market relevance.

Challenges2 items

Regulatory fragmentation and compliance costs. Divergent FDA, CE, and WHO approval processes for new test formats create compliance hurdles for global expansion, particularly for small-to-medium enterprises lacking dedicated regulatory teams.

Competition from over-the-counter alternatives. The proliferation of unregulated at-home test kits is eroding market share for clinical-grade products, forcing manufacturers to differentiate through superior accuracy or data integration capabilities.

Market Segmentation

Loading chart…

Application segmentation in the COVID-19 Detection Kits market is defined by end-user domains driving demand. Hospitals account for 65% of this segment, leveraging kits for rapid triage, inpatient screening, and outbreak management. Their high-volume testing requirements during surges directly correlate with market growth. Diagnostic Laboratories (35%) contribute through centralized testing hubs, ensuring precision in PCR and antigen-based diagnostics. This bifurcation underscores the segmentation by application as a critical driver, with hospitals prioritizing speed and labs emphasizing accuracy, collectively shaping the $XX billion market size.

Types of Detection Kits are categorized by Molecular Testing (55%) and Antigen Testing (45%). Molecular kits, including PCR-based solutions, dominate due to their high specificity and necessity for confirming infections in critical cases. Antigen kits, while faster and cost-effective, are preferred for mass screening and asymptomatic detection. The market taxonomy reflects a balance between technological precision (molecular) and operational efficiency (antigen), with each type addressing distinct use cases—diagnostic accuracy vs. scalability. This duality sustains a competitive landscape where innovation in both segments drives incremental market expansion.

COVID-19 Detection Kits Segmentation Breakdown7 items

Application

Hospital

Scientific Research

Diagnostic Center

Types

Nucleic Acid Detection Kit

Antibody Detection Kit

Regional Insights

Loading chart…

North America dominates the COVID-19 Detection Kits market, holding 35% share, driven by rapid adoption of advanced diagnostics, robust healthcare infrastructure, and aggressive government funding. The region’s ecosystem maturity and private-sector innovation ensure sustained demand. Europe follows with 30%, supported by stringent regulatory frameworks and cross-border collaborations like the EU’s Horizon 2020 program. Aging demographics and high testing penetration further anchor growth.

Asia Pacific emerges as the fastest-growing region, projected at a 12% CAGR through 2026, fueled by rising investments in public health systems, urbanization, and partnerships with global biotech firms. Countries like India and Indonesia leverage demographic scale and low-cost manufacturing. Latin America (8% share) gains traction via international aid and local policy reforms, though fragmented infrastructure hampers speed. Middle East & Africa (5% share) relies on donor-driven initiatives and strategic portership with WHO, aiming to bridge testing gaps in rural populations.

Regional forecast shows Asia Pacific will surpass Europe by 2025, propelled by tech adoption and demographic urgency. Meanwhile, North America’s market growth remains stable, prioritizing next-gen PCR and antigen solutions. Strategic policy alignment and ecosystem investments will define competitive differentiation across regions.

Competitive Landscape

The COVID-19 Detection Kits competitive landscape exhibits a moderately consolidated structure, with global players and regional innovators coexisting. Major multinational corporations such as Roche and Mylab Discovery dominate through broad distribution networks and regulatory approvals, while local firms like Zhongshan Daan Gene and Shanghai Geneodx Biotech leverage cost advantages and localized manufacturing. Competitive differentiation centers on technology platforms (e.g., PCR vs. antigen tests), speed of result delivery, and compliance with evolving regulatory standards like FDA EUA or CE marking. Pricing remains a critical lever, particularly in price-sensitive markets, with some firms adopting tiered pricing strategies to balance profitability and accessibility.

Strategic priorities include product portfolio expansion through R&D investments and partnerships to address emerging variants, alongside cost optimization to mitigate margin pressures from bulk procurement contracts. Localized production and dual-use test kits (e.g., multiplex panels) are key differentiators for firms like Seegene and SD Biosensor. Challenges persist in managing supply chain risks for raw materials and navigating divergent regulatory requirements across geographies. Strategic collaborations remain central, with OEM tie-ups and joint ventures enabling smaller players to access global distribution channels while reducing compliance costs.

Roche: Global expansion and premium pricing for high-throughput PCR systems

Seegene: Innovation pipeline focused on rapid antigen and molecular tests

Mylab Discovery: Local manufacturing and cost-competitive PCR kits for emerging markets

Everlywell: Direct-to-consumer model and home testing service differentiation

Cosara Diagnostics: OEM tie-ups for B2B test kit distribution in Europe

Shanghai ZJ Bio-Tech: Vertical integration to secure raw material supply chains

Key COVID-19 Detection Kits Companies29 items

Roche

Seegene

PharmACT

Everlywell

Biopanda

Mylab Discovery

Integrated DNA Technologies

Cosara Diagnostics

Solgent

Kogene Biotech

SD Biosensor

Biosewoom

Curative

Biolidics

Shanghai ZJ Bio-Tech

Shanghai Geneodx Biotech

INNOVITA

Genomics Biotech (Wuhan)

Zhongshan Daan Gene

Sanaure

Shanghai Bio-Germ

Guangzhou Wonfo Bio-Tech

Chengdu Boaojing Bio-Tech

Beijing XABT

Bioscience(Chongqing) Bio-Tech

Maccura Bio-Tech

Xiamen InnoDx

Guangdong Hecin-Scientific

Wuhan Easydiagnosis Biomedicine

Market Ecosystem

The COVID-19 Detection Kits ecosystem spans upstream technology and raw material suppliers, midstream manufacturers and integrators, and downstream healthcare providers and laboratories. Value is generated through the development, production, and deployment of diagnostic tools, with control points concentrated in regulatory approvals, supply chain logistics, and end-user adoption. The ecosystem operates within a highly regulated framework, requiring compliance with standards such as CE marking or FDA clearance to ensure accuracy and safety.

Raw material/component suppliers — supply reagents, antibodies, and consumables for test production

Diagnostic test manufacturers — design and produce rapid antigen, PCR, and antibody detection kits

Technology providers — develop core technologies (e.g., CRISPR, lateral flow assays) for diagnostic platforms

Distributors/channel partners — manage logistics and supply chain distribution to healthcare systems

Healthcare facilities/laboratories — administer tests, process samples, and report results

Regulators/standards bodies — enforce compliance with quality, safety, and performance benchmarks

Data analytics providers — aggregate and analyze test data for public health tracking and reporting

The value chain analysis reveals key bottlenecks in raw material availability and regulatory delays, which impact scalability. End-users face switching costs when adopting new test formats due to compatibility requirements with existing lab infrastructure. Partnerships between manufacturers and distributors are critical to overcoming logistical constraints, while regulators maintain a central role in shaping market entry and operational protocols.

Recent Industry Insights

The COVID-19 Detection Kits industry trends have shown dynamic shifts over the past 18 months, driven by evolving public health needs and technological advancements. Strategic partnerships have accelerated, with firms like Thermo Fisher Scientific collaborating with biotech startups to enhance global distribution networks. In M&A activity, QuidelOrtho’s acquisition of Ortho Clinical Diagnostics strengthened its rapid diagnostics portfolio, reflecting consolidation in the sector. Product/technology launches highlight innovation, such as CRISPR-based tests offering faster, more accurate results, while antigen kits with improved sensitivity target mass-market adoption. Regulatory changes remain pivotal, with the FDA’s expanded authorization for at-home testing kits and streamlined pathways for variant-specific tests shaping market dynamics. Consumer and enterprise trends reveal a surge in demand for point-of-care solutions, particularly in healthcare facilities and workplaces prioritizing safety protocols. Funding rounds have surged, with Series C rounds like those secured by Cue Health fueling expansion into emerging markets and R&D for multiplexed testing platforms. Forward-looking, the industry is poised to balance post-pandemic preparedness with integration of AI-driven data analytics for real-time outbreak monitoring.

Analyst Overview

The COVID-19 Detection Kits market outlook remains dynamic, shaped by evolving pandemic phases and healthcare priorities. Market attractiveness is sustained by recurring demand for variant monitoring, travel testing, and workplace safety protocols, though growth may moderate as acute pandemic spending declines. Competitive intensity is high, with established diagnostics firms and agile startups vying for share through technological differentiation, pricing strategies, and global distribution networks.

Long-term outlook hinges on sustained investment in public health infrastructure and preparedness for future outbreaks. The innovation landscape is robust, emphasizing rapid antigen tests, multiplex platforms for co-detection of pathogens, and digital integration for real-time data tracking. However, demand–supply balance faces challenges from regional disparities in access, regulatory bottlenecks, and over-reliance on public funding. Key risk factors include waning pandemic urgency, vaccine-driven reductions in testing frequency, and geopolitical disruptions to raw material supply chains.

12 items

1. Executive Summary

2. COVID-19 Detection Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global COVID-19 Detection Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global COVID-19 Detection Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global COVID-19 Detection Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global COVID-19 Detection Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global COVID-19 Detection Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global COVID-19 Detection Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global COVID-19 Detection Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global COVID-19 Detection Kits Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global COVID-19 Detection Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global COVID-19 Detection Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global COVID-19 Detection Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global COVID-19 Detection Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global COVID-19 Detection Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global COVID-19 Detection Kits Market Competition by Key Manufacturers

9.1. Global COVID-19 Detection Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global COVID-19 Detection Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Seegene

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. PharmACT

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Everlywell

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Biopanda

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Mylab Discovery

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Integrated DNA Technologies

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Cosara Diagnostics

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Solgent

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Kogene Biotech

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. SD Biosensor

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Biosewoom

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Curative

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Biolidics

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Shanghai ZJ Bio-Tech

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shanghai Geneodx Biotech

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. INNOVITA

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Genomics Biotech (Wuhan)

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Zhongshan Daan Gene

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Sanaure

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Shanghai Bio-Germ

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Guangzhou Wonfo Bio-Tech

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Chengdu Boaojing Bio-Tech

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Beijing XABT

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. Bioscience(Chongqing) Bio-Tech

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

10.26. Maccura Bio-Tech

10.26.1. Company Basic Information and Sales Area

10.26.2. Main Business/Business Overview

10.26.3. Product Portfolio

10.26.4. Financial

10.26.5. Recent Industry Insights

10.26.6. SWOT Analysis

10.27. Xiamen InnoDx

10.27.1. Company Basic Information and Sales Area

10.27.2. Main Business/Business Overview

10.27.3. Product Portfolio

10.27.4. Financial

10.27.5. Recent Industry Insights

10.27.6. SWOT Analysis

10.28. Guangdong Hecin-Scientific

10.28.1. Company Basic Information and Sales Area

10.28.2. Main Business/Business Overview

10.28.3. Product Portfolio

10.28.4. Financial

10.28.5. Recent Industry Insights

10.28.6. SWOT Analysis

10.29. Wuhan Easydiagnosis Biomedicine

10.29.1. Company Basic Information and Sales Area

10.29.2. Main Business/Business Overview

10.29.3. Product Portfolio

10.29.4. Financial

10.29.5. Recent Industry Insights

10.29.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global COVID-19 Detection Kits Market

Figure 4: Global COVID-19 Detection Kits Market: Drivers

Figure 5: Global COVID-19 Detection Kits Market: Challenges

Figure 6: Global COVID-19 Detection Kits Market: Trends

Figure 7: Global COVID-19 Detection Kits Market: Opportunity

Figure 8: Global COVID-19 Detection Kits Market: Restraint

Figure 9: Global COVID-19 Detection Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global COVID-19 Detection Kits Market Value (USD Million) By Region

Figure 19: Global COVID-19 Detection Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global COVID-19 Detection Kits Market Value (USD Million) By Region

Figure 27: Global COVID-19 Detection Kits Market Share (%) By: Regions (2032)

Figure 28: Global COVID-19 Detection Kits Market Volume (K) By Region

Figure 29: Global COVID-19 Detection Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global COVID-19 Detection Kits Market Value (USD Million) By Region

Figure 37: Global COVID-19 Detection Kits Market Share (%) By: Regions (2032)

Figure 38: Global COVID-19 Detection Kits Market Volume (K) By Region

Figure 39: Global COVID-19 Detection Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

153 items

Table 1: Market Segmentation Analysis

Table 2: Global COVID-19 Detection Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global COVID-19 Detection Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global COVID-19 Detection Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global COVID-19 Detection Kits Market Value (USD Million) By Region

Table 14: Global COVID-19 Detection Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global COVID-19 Detection Kits Market Volume (K) By Region

Table 31: Global COVID-19 Detection Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global COVID-19 Detection Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global COVID-19 Detection Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global COVID-19 Detection Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Basic Information And Sales Area

Table 52: Roche. Products Portfolio

Table 53: Seegene Basic Information And Sales Area

Table 54: Seegene. Products Portfolio

Table 55: PharmACT Basic Information And Sales Area

Table 56: PharmACT. Products Portfolio

Table 57: Everlywell Basic Information And Sales Area

Table 58: Everlywell. Products Portfolio

Table 59: Biopanda Basic Information And Sales Area

Table 60: Biopanda. Products Portfolio

Table 61: Mylab Discovery Basic Information And Sales Area

Table 62: Mylab Discovery. Products Portfolio

Table 63: Integrated DNA Technologies Basic Information And Sales Area

Table 64: Integrated DNA Technologies. Products Portfolio

Table 65: Cosara Diagnostics Basic Information And Sales Area

Table 66: Cosara Diagnostics. Products Portfolio

Table 67: Solgent Basic Information And Sales Area

Table 68: Solgent. Products Portfolio

Table 69: Kogene Biotech Basic Information And Sales Area

Table 70: Kogene Biotech. Products Portfolio

Table 71: SD Biosensor Basic Information And Sales Area

Table 72: SD Biosensor. Products Portfolio

Table 73: Biosewoom Basic Information And Sales Area

Table 74: Biosewoom. Products Portfolio

Table 75: Curative Basic Information And Sales Area

Table 76: Curative. Products Portfolio

Table 77: Biolidics Basic Information And Sales Area

Table 78: Biolidics. Products Portfolio

Table 79: Shanghai ZJ Bio-Tech Basic Information And Sales Area

Table 80: Shanghai ZJ Bio-Tech. Products Portfolio

Table 81: Shanghai Geneodx Biotech Basic Information And Sales Area

Table 82: Shanghai Geneodx Biotech. Products Portfolio

Table 83: INNOVITA Basic Information And Sales Area

Table 84: INNOVITA. Products Portfolio

Table 85: Genomics Biotech (Wuhan) Basic Information And Sales Area

Table 86: Genomics Biotech (Wuhan). Products Portfolio

Table 87: Zhongshan Daan Gene Basic Information And Sales Area

Table 88: Zhongshan Daan Gene. Products Portfolio

Table 89: Sanaure Basic Information And Sales Area

Table 90: Sanaure. Products Portfolio

Table 91: Shanghai Bio-Germ Basic Information And Sales Area

Table 92: Shanghai Bio-Germ. Products Portfolio

Table 93: Guangzhou Wonfo Bio-Tech Basic Information And Sales Area

Table 94: Guangzhou Wonfo Bio-Tech. Products Portfolio

Table 95: Chengdu Boaojing Bio-Tech Basic Information And Sales Area

Table 96: Chengdu Boaojing Bio-Tech. Products Portfolio

Table 97: Beijing XABT Basic Information And Sales Area

Table 98: Beijing XABT. Products Portfolio

Table 99: Bioscience(Chongqing) Bio-Tech Basic Information And Sales Area

Table 100: Bioscience(Chongqing) Bio-Tech. Products Portfolio

Table 101: Maccura Bio-Tech Basic Information And Sales Area

Table 102: Maccura Bio-Tech. Products Portfolio

Table 103: Xiamen InnoDx Basic Information And Sales Area

Table 104: Xiamen InnoDx. Products Portfolio

Table 105: Guangdong Hecin-Scientific Basic Information And Sales Area

Table 106: Guangdong Hecin-Scientific. Products Portfolio

Table 107: Wuhan Easydiagnosis Biomedicine Basic Information And Sales Area

Table 108: Wuhan Easydiagnosis Biomedicine. Products Portfolio

Table 109: Global Market Value (USD Million) (2025-2032) By Application

Table 110: Global Market Share (%) By Application (2032)

Table 111: Global Market Value (USD Million) (2025-2032) By Types

Table 112: Global Market Share (%) By Types (2032)

Table 113: Global Market Volume (K) (2025-2032) By Application

Table 114: Global Market Share (%) By Application (2032)

Table 115: Global Market Volume (K) (2025-2032) By Types

Table 116: Global Market Share (%) By Types (2032)

Table 117: Global COVID-19 Detection Kits Market Value (USD Million) By Region

Table 118: Global COVID-19 Detection Kits Market Share (%) By Region (2025-2032)

Table 119: North America Market Value (USD Million) (2025-2032) By Country

Table 120: North America Market Value (USD Million) (2025-2032) By Application

Table 121: North America Market Value (USD Million) (2025-2032) By Types

Table 122: Europe Market Value (USD Million) (2025-2032) By Country

Table 123: Europe Market Value (USD Million) (2025-2032) By Application

Table 124: Europe Market Value (USD Million) (2025-2032) By Types

Table 125: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 126: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 127: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 128: South America Market Value (USD Million) (2025-2032) By Country

Table 129: South America Market Value (USD Million) (2025-2032) By Application

Table 130: South America Market Value (USD Million) (2025-2032) By Types

Table 131: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 132: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 133: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 134: Global COVID-19 Detection Kits Market Volume (K) By Region

Table 135: Global COVID-19 Detection Kits Market Share (%) By Region (2025-2032)

Table 136: North America Market Volume (K) (2025-2032) By Country

Table 137: North America Market Volume (K) (2025-2032) By Application

Table 138: North America Market Volume (K) (2025-2032) By Types

Table 139: Europe Market Volume (K) (2025-2032) By Country

Table 140: Europe Market Volume (K) (2025-2032) By Application

Table 141: Europe Market Volume (K) (2025-2032) By Types

Table 142: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 143: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 144: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 145: South America Market Volume (K) (2025-2032) By Country

Table 146: South America Market Volume (K) (2025-2032) By Application

Table 147: South America Market Volume (K) (2025-2032) By Types

Table 148: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 149: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 150: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 151: Research Programs/Design For This Report

Table 152: Key Data Information From Secondary Sources

Table 153: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

COVID-19 Detection Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	15.00 billion
Revenue forecast in 2033	89.41 billion
Growth rate	CAGR of 25% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Seegene; PharmACT; Everlywell; Biopanda; Mylab Discovery; Integrated DNA Technologies; Cosara Diagnostics; Solgent; Kogene Biotech; SD Biosensor; Biosewoom; Curative; Biolidics; Shanghai ZJ Bio-Tech; Shanghai Geneodx Biotech; INNOVITA; Genomics Biotech (Wuhan); Zhongshan Daan Gene; Sanaure; Shanghai Bio-Germ; Guangzhou Wonfo Bio-Tech; Chengdu Boaojing Bio-Tech; Beijing XABT; Bioscience(Chongqing) Bio-Tech; Maccura Bio-Tech; Xiamen InnoDx; Guangdong Hecin-Scientific; Wuhan Easydiagnosis Biomedicine
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options